Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2016 1
2017 1
2018 1
2019 1
2020 3
2021 6
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Methylation of tumour suppressor genes associated with thyroid cancer.
Botezatu A, Iancu IV, Plesa A, Manda D, Popa O, Bostan M, Mihaila M, Albulescu A, Fudulu A, Vladoiu SV, Huica I, Dobrescu R, Anton G, Badiu C. Botezatu A, et al. Among authors: manda d. Cancer Biomark. 2019;25(1):53-65. doi: 10.3233/CBM-182265. Cancer Biomark. 2019. PMID: 31006665
Serum soluble urokinase plasminogen activator receptor as a potential biomarker of renal impairment severity in diabetic nephropathy.
Lupușoru G, Ailincăi I, Sorohan BM, Andronesi A, Achim C, Micu G, Caragheorgheopol A, Manda D, Lupușoru M, Ismail G. Lupușoru G, et al. Among authors: manda d. Diabetes Res Clin Pract. 2021 Dec;182:109116. doi: 10.1016/j.diabres.2021.109116. Epub 2021 Oct 30. Diabetes Res Clin Pract. 2021. PMID: 34728182 Free article.
Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV, Botezatu A, Plesa A, Huica I, Fudulu A, Albulescu A, Bostan M, Mihaila M, Grancea C, Manda DA, Dobrescu R, Vladoiu SV, Anton G, Badiu CV. Iancu IV, et al. Among authors: manda da. Cancer Biomark. 2020;28(2):255-268. doi: 10.3233/CBM-190871. Cancer Biomark. 2020. PMID: 32390600
17 results